Chemotherapy Combined With Pembrolizumab in Treating Patients With Thymoma and Thymic Carcinoma
Clinical trial NCT04554524 · UNKNOWN
Trial details
- NCT number
- NCT04554524
- Sponsor
- Tang-Du Hospital
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2020-08-27
- Primary completion
- 2024-07-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.